הכנסות ברוטו של החברה dyadic.com (DYAI)

Sales performance dynamics for Dyadic International (DYAI) confirm the effectiveness of the C1 platform management in extracting profit from patents. The value of 0.00 represents the current realization rate. Stable B2B relationships in the vaccine sector and expansion into agritech are strengthening the ecosystem. However, geopolitical risks and the potential cancellation of licenses during conflict periods pose threats to the supply chains of active substances.

Selecting assets with a high margin of safety begins with an analysis of real cash flows. This indicator captures actual sales revenue, reflecting the balance between operational business reliability and market risks. For Dyadic International (DYAI), this represents the volume of payments for licensing the C1 fungal platform in vaccine production. The dynamics of these inflows determine the company's sales growth rate, visualizing the effectiveness of its intellectual property monetization.